Sequent Scientific Limited has received prequalification approval from the WHO for Albendazole API, which validates its manufacturing capabilities and supports its mission to provide affordable medicines globally. The companys consolidated turnover for FY24 was Rs 13.69 billion, and it operates in over 90 countries.